Species: Actinomyces graevenitzii (HMT-0866) Primary Body Site: Oral
Download Options
LINKS: Ecology Home
| HMT-0866: [Body Sites Data]
[Taxon Description]
| Life Page: Actinomyces graevenitzii
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.01 | 0.01 | 0.01 | 0.03 | 0.11 | 0.05 | 0.37 | 1.91 | 1.49 | 2.20 | 0.06 | 0.01 | 0.01 | 0.07 | 0 | 0.01 | 0.01 | 0.02 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0 | 0 | 0 | 0 | 0.01 | 0.05 | 0.05 | 0.32 | 0.14 | 0.25 | 0 | 0 | 0 | 0.07 | 0 | 0 | 0 | 0 |
| 90thp | 0.02 | 0.01 | 0.02 | 0.11 | 0.30 | 0.05 | 1.01 | 4.31 | 4.22 | 5.03 | 0.08 | 0.02 | 0.03 | 0.07 | 0 | 0.02 | 0.04 | 0.01 |
| Stdev | 0.01 | 0.08 | 0.01 | 0.05 | 0.21 | 0 | 0.43 | 2.37 | 2.37 | 2.10 | 0.16 | 0.01 | 0.02 | 0 | 0 | 0.02 | 0.02 | 0.18 |
| Prev(%) | 4.17 | 2.03 | 0 | 13.33 | 20.74 | 100.00 | 50.00 | 85.71 | 81.82 | 97.40 | 3.08 | 0 | 3.33 | 0 | 0 | 0 | 0 | 1.33 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.01 | 0 | 0.02 | 0.14 | 0.93 | 0.46 | 1.78 | 1.46 | 2.51 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 |
| 90thp | 0 | 0 | 0.07 | 0.37 | 2.16 | 1.10 | 3.79 | 4.31 | 6.16 | 0 |
| Stdev | 0.04 | 0 | 0.05 | 0.33 | 2.04 | 0.99 | 3.12 | 2.17 | 3.95 | 0 |
| Prev(%) | 3.90 | 3.90 | 20.78 | 59.74 | 85.71 | 79.22 | 85.71 | 88.31 | 93.51 | 0 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.02 | 0.01 | 0.02 | 0.08 | 0.47 | 0.21 | 0.76 | 0.62 | 1.03 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0.03 | 0.29 | 1.05 | 0.44 | 1.62 | 1.64 | 2.34 | 0 |
| Stdev | 0.17 | 0.06 | 0.10 | 0.16 | 1.11 | 0.48 | 1.19 | 1.11 | 1.77 | 0 |
| Prev(%) | 3.38 | 4.73 | 16.22 | 50.00 | 81.76 | 69.59 | 89.86 | 85.14 | 87.84 | 0.70 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0 | 0.04 | 0 | 1.00 | 0.46 | 1.77 | 1.36 | 2.13 | 0 | 0 | 0 | 0.08 | 0.08 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | 0.01 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0.07 | 0 | 2.28 | 1.48 | 4.41 | 3.43 | 4.35 | 0 | 0 | 0 | 0.06 | 0.10 | 0 | 0 | 0 | 0 |
| Stdev | 0 | 0 | 0.17 | 0 | 2.06 | 1.01 | 2.35 | 2.11 | 3.07 | 0 | 0 | 0 | 0.33 | 0.50 | 0 | 0 | 0 | 0 |
| Prev(%) | 0 | 0 | 32.87 | 0 | 88.59 | 73.08 | 91.96 | 90.00 | 95.48 | 0 | 0 | 0 | 17.24 | 17.51 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0 | 0 | 0.25 | 1.62 | 0.62 | 2.20 | 1.70 | 2.47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0.06 | 0 | 0.08 | 0.05 | 0.15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0.75 | 3.81 | 1.61 | 5.57 | 4.49 | 6.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0 | 0 | 0 | 0.45 | 2.33 | 1.11 | 2.74 | 2.38 | 2.94 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 0 | 0 | 0 | 61.04 | 92.58 | 85.12 | 91.59 | 93.19 | 95.86 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0 | 0 | 0.03 | 0.08 | 0.32 | 0.57 | 0.91 | 0.69 | 0.81 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.07 | 0.05 | 0 | 0 |
| 90thp | 0.01 | 0.01 | 0.10 | 0.28 | 1.09 | 1.75 | 2.15 | 1.05 | 1.71 | 0 |
| Stdev | 0.01 | 0.01 | 0.06 | 0.14 | 0.44 | 0.96 | 1.31 | 1.32 | 1.54 | 0 |
| Prev(%) | 29.73 | 26.47 | 58.14 | 71.43 | 92.86 | 96.00 | 96.97 | 100.00 | 92.50 | 10.00 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0.01 | 0 | 0.02 | 0.14 | 0.05 | 0.35 | 1.38 | 1.77 | 2.32 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0.05 | 0.05 | 0.04 | 0.14 | 0.24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0.08 | 0.41 | 0.05 | 0.92 | 2.91 | 6.28 | 5.49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.01 | 0.09 | 0 | 0.06 | 0.29 | 0 | 0.41 | 1.70 | 2.65 | 2.25 | 0.13 | 0 | 0.02 | 0 | 0 | 0 | 0.09 | 0.17 |
| Prev(%) | 4.17 | 3.03 | 4.17 | 23.53 | 52.93 | 100.00 | 100.00 | 87.50 | 100.00 | 97.42 | 3.60 | 0 | 3.13 | 0 | 0 | 0 | 3.03 | 1.82 |

